Visual outcomes following high water-content hydrophobic acrylic trifocal intraocular lens implantation.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
28 Oct 2024
Historique:
received: 23 01 2024
accepted: 17 10 2024
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 28 10 2024
Statut: epublish

Résumé

To prospectively evaluate binocular visual outcomes after implantation of trifocal intraocular lenses (IOLs) with high-water-content hydrophobic acrylic material in Japanese patients. In 59 patients (mean age 65.1 ± 7.9 years), Clareon PanOptix (CNWTT0: Alcon) with a high-water-content hydrophobic acrylic material was implanted bilaterally. Three months postoperatively, binocular uncorrected visual acuity (BUCVA) and distance-corrected visual acuity (BDCVA) at distances of 5 m, 80, 60, and 40 cm, binocular defocus curves, and binocular photopic contrast sensitivity were examined. Subjective symptoms (night vision disturbance, glare, halos, haze, or blurry vision) were also assessed. The mean postoperative BUCVA/BDCVA at 5 m, 80 cm, 60 cm, and 40 cm were - 0.115/-0.163, -0.052/-0.047, -0.054/-0.075, and - 0.043/-0.067 logMAR, respectively. A smooth defocus curve, contrast sensitivity within the normal range, and acceptable subjective symptom rates were obtained. The trifocal IOL, composed of a high-water-content hydrophobic acrylic material, provides good continuous binocular vision from distance to near. This investigator-initiated study was registered in the Japan Registry for Clinical Trials (identifier: jRCTs032220042) on April 26, 2022.

Sections du résumé

BACKGROUND BACKGROUND
To prospectively evaluate binocular visual outcomes after implantation of trifocal intraocular lenses (IOLs) with high-water-content hydrophobic acrylic material in Japanese patients.
METHODS METHODS
In 59 patients (mean age 65.1 ± 7.9 years), Clareon PanOptix (CNWTT0: Alcon) with a high-water-content hydrophobic acrylic material was implanted bilaterally. Three months postoperatively, binocular uncorrected visual acuity (BUCVA) and distance-corrected visual acuity (BDCVA) at distances of 5 m, 80, 60, and 40 cm, binocular defocus curves, and binocular photopic contrast sensitivity were examined. Subjective symptoms (night vision disturbance, glare, halos, haze, or blurry vision) were also assessed.
RESULTS RESULTS
The mean postoperative BUCVA/BDCVA at 5 m, 80 cm, 60 cm, and 40 cm were - 0.115/-0.163, -0.052/-0.047, -0.054/-0.075, and - 0.043/-0.067 logMAR, respectively. A smooth defocus curve, contrast sensitivity within the normal range, and acceptable subjective symptom rates were obtained.
CONCLUSIONS CONCLUSIONS
The trifocal IOL, composed of a high-water-content hydrophobic acrylic material, provides good continuous binocular vision from distance to near.
TRIAL REGISTRATION BACKGROUND
This investigator-initiated study was registered in the Japan Registry for Clinical Trials (identifier: jRCTs032220042) on April 26, 2022.

Identifiants

pubmed: 39465378
doi: 10.1186/s12886-024-03735-9
pii: 10.1186/s12886-024-03735-9
doi:

Substances chimiques

Acrylic Resins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

469

Informations de copyright

© 2024. The Author(s).

Références

Tañá-Rivero P, Rodríguez-Carrillo MD, Tañá-Sanz P, Ruiz-Santos M, Tañá-Sanz S. Clinical outcomes of trifocal toric intraocular lenses. Eur J Ophthalmol. 2023;33:1773–85.
doi: 10.1177/11206721231155047 pubmed: 36788496
Zhu D, Ren S, Mills K, Hull J, Dhariwal M. Rate of complete spectacle independence with a Trifocal Intraocular Lens: a systematic literature review and Meta-analysis. Ophthalmol Ther. 2023;12:1157–71.
doi: 10.1007/s40123-023-00657-5 pubmed: 36745314 pmcid: 10011212
Werner L, Thatthamla I, Ong M, Schatz H, Garcia-Gonzalez M, Gros-Otero J, Cañones-Zafra R, Teus MA. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45:1490–7.
doi: 10.1016/j.jcrs.2019.05.017 pubmed: 31399323
Werner L. Glistenings and surface light scattering in intraocular lenses. J Cataract Refract Surg. 2010;36:1398–420.
doi: 10.1016/j.jcrs.2010.06.003 pubmed: 20656166
Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46:682–7.
doi: 10.1097/j.jcrs.0000000000000142 pubmed: 32358260
Kinoshita K, Miyata K, Nejima R, Honbo R, Mori M, Minami Y. Surface light scattering from 1-piece hydrophobic acrylic intraocular lenses with hydroxyethyl methacrylate: contralateral observation for 7 years. J Cataract Refract Surg. 2021;47:702–5.
doi: 10.1097/j.jcrs.0000000000000621 pubmed: 33769764
Khoramnia R, Naujokaitis T, Baur ID, Hassel O, Henningsen N, Reitemeyer E, Chychko L, Łabuz G, Auffarth GU. Functional outcomes after refractive Lens Exchange with Implantation of a glistening-free Diffractive Trifocal intraocular Lens. Am J Ophthalmol. 2024;268:296–305.
doi: 10.1016/j.ajo.2024.07.037 pubmed: 39117256
Jo E, Kim B, Kim TI, Kim MK, Choi CY. Clinical outcomes of a new hydrophobic trifocal intraocular Lens with Hydroxyethyl Methacrylate in cataract surgery: a prospective Multicenter Study. Korean J Ophthalmol. 2024;38:212–20.
doi: 10.3341/kjo.2023.0140 pubmed: 38644651 pmcid: 11175982
Kohnen T, Marchini G, Alfonso JF, Bala C, Cochener B, Martinez A, Carreño E. Innovative trifocal (quadrifocal) presbyopia-correcting IOLs: 1-year outcomes from an international multicenter study. J Cataract Refract Surg. 2020;46:1142–8.
doi: 10.1097/j.jcrs.0000000000000232 pubmed: 32358415 pmcid: 7688079
Fernández J, Ribeiro FJ, Rodríguez-Vallejo M, Dupps WJ Jr, Werner L, Srinivasan S, Kohnen T. Standard for collecting and reporting outcomes of IOL-based refractive surgery: update for enhanced monofocal, EDOF, and multifocal IOLs. J Cataract Refract Surg. 2022;48:1235–41.
doi: 10.1097/j.jcrs.0000000000001013 pubmed: 36315627
Bissen-Miyajima H, Ota Y, Hayashi K, Igarashi C, Sasaki N. Results of a clinical evaluation of a trifocal intraocular lens in Japan. Jpn J Ophthalmol. 2020;64:140–9.
doi: 10.1007/s10384-019-00712-4 pubmed: 31900871
Kohnen T, Lapid-Gortzak R, Ramamurthy D, Bissen-Miyajima H, Maxwell A, Kim TI, Modi S. Clinical outcomes after bilateral implantation of a diffractive trifocal intraocular Lens: a Worldwide Pooled analysis of prospective clinical investigations. Clin Ophthalmol. 2023;17:155–63. https://doi.org/10.2147/OPTH.S377234 .
doi: 10.2147/OPTH.S377234 pubmed: 36647516 pmcid: 9840399
Modi S, Lehmann R, Maxwell A, Solomon K, Cionni R, Thompson V, Horn J, Caplan M, Fisher B, Hu JG, Yeu E. Visual and patient-reported outcomes of a Diffractive Trifocal Intraocular Lens Compared with those of a Monofocal Intraocular Lens. Ophthalmology. 2021;128:197–207.
doi: 10.1016/j.ophtha.2020.07.015 pubmed: 33004211
Nuijts RMMA, Bhatt U, Nanavaty MA, Roberts TV, Peterson R, Teus MA. Three-year multinational clinical study on an aspheric hydrophobic acrylic intraocular lens. J Cataract Refract Surg. 2023;49:672–8.
doi: 10.1097/j.jcrs.0000000000001173 pubmed: 36848238 pmcid: 10284131
Wang CX, Lin N, Guo YX. Visual requirement for Chinese reading with normal vision. Brain Behav. 2019;9:e01216. https://doi.org/10.1002/brb3.1216 .
doi: 10.1002/brb3.1216 pubmed: 30793523 pmcid: 6456801
Hayashi K, Yoshida M, Igarashi C, Hirata A. Effect of refractive astigmatism on all-distance visual acuity in eyes with a trifocal intraocular lens. Am J Ophthalmol. 2021;221:279–86.
doi: 10.1016/j.ajo.2020.07.051 pubmed: 32777380

Auteurs

Takayoshi Suzuki (T)

Totsuka-ekimae Suzuki Eye Clinic, Yokohama, Japan.

Yuka Ota (Y)

Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, 2-9-18 KandaMisaki-cho, Chiyoda-ku, Tokyo, 101-0061, Japan.

Hisaharu Suzuki (H)

Zengyo Suzuki Eye Clinic, Fujisawa, Japan.

Seiichiro Hata (S)

Yokohama Sky Eye Clinic, Yokohama, Japan.

Keiichiro Minami (K)

Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, 2-9-18 KandaMisaki-cho, Chiyoda-ku, Tokyo, 101-0061, Japan. minami@miyata-med.ne.jp.

Hiroko Bissen-Miyajima (H)

Department of Ophthalmology, Tokyo Dental College Suidobashi Hospital, 2-9-18 KandaMisaki-cho, Chiyoda-ku, Tokyo, 101-0061, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH